National utilization and outcomes of robotic pancreatoduodenectomy
HPB · 2026
DOI: 10.1016/j.hpb.2026.02.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2026. Verfasst von Patrick W Underwood und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, University of Florida, Gainesville, FL, 32608, USA. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Robotic Surgical Procedures, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Minimally-invasive approaches to pancreatic surgery are increasingly utilized. We aimed to evaluate the implementation of robotic pancreatoduodenectomy (RPD) across the United States. METHODS: The National Cancer Database was queried for all patients undergoing pancreatoduodenectomy (PD) for pancreatic cancer in the United States between 2010 and 2020. The primary outcome was utlization of robotic PD. Secondary outcomes included perioperative outcomes following PD. RESULTS: There were 48,781 patients who underwent PD with 78.0 % and 5.2 % performed by an open and robotic approach, respectively. Utilization of RPD increased from 1.1 % to 10.3 % between 2010 and 2020 (p < 0.001). Robotic converted to open PD decreased from 22.2 % to 11.1 % over the study period (p = 0.006). Patients undergoing open or RPD had similar R0 resection, 30-day unplanned readmission, and 90-day mortality. The 10 highest volume centers for RPD performed 41.8 % of all RPD and had lower rates of conversion to open, post-operative length of stay, and a higher number of lymph nodes examined compared with other centers performing RPD (all p < 0.001). CONCLUSION: Robotic PD is increasingly utilized in the United States but still represents a small fraction of patients undergoing PD. Given improved outcomes observed in high-volume centers, deliberate initiatives to expand RPD programs while ensuring continued centralization are important.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Surgical Oncology, Department of Surgery, University of Florida, Gainesville, FL, 32608, USA.
- Biostatistics Shared Resource Core, University of Illinois Cancer Center, Chicago, IL, 60612, USA.
- Biostatistics Shared Resource Core, University of Illinois Cancer Center, Chicago, IL, 60612, USA; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, 606…
- Division of Surgical Oncology, Department of Surgery, University of Illinois-Chicago, Chicago, IL, 60612, USA.
- Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
- Division of Surgical Oncology, Department of Surgery, University of Illinois-Chicago, Chicago, IL, 60612, USA. Electronic address: aejaz@uic.edu.
Zitieren
APA
Underwood, P. W., Ma, W., Xu, Z., Chen, Z., White, B., Dillhoff, M., Cloyd, J. M., Tsai, S., Pawlik, T. M., & Ejaz, A. (2026). National utilization and outcomes of robotic pancreatoduodenectomy. HPB. https://doi.org/10.1016/j.hpb.2026.02.003
Vancouver
Underwood PW, Ma W, Xu Z, Chen Z, White B, Dillhoff M, et al. National utilization and outcomes of robotic pancreatoduodenectomy. HPB. 2026. doi:10.1016/j.hpb.2026.02.003
BibTeX
@article{Underwood2026,
author = {Underwood, Patrick W and Ma, Weiwei and Xu, Ziqiao and Chen, Zhengjia and White, Bradley and Dillhoff, Mary and Cloyd, Jordan M and Tsai, Susan and Pawlik, Timothy M and Ejaz, Aslam},
title = {National utilization and outcomes of robotic pancreatoduodenectomy},
journal = {HPB},
year = {2026},
doi = {10.1016/j.hpb.2026.02.003}
}
EUVIMED